IGENICA

igenica-logo

Igenica Biotherapeutics is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. They are the only biotherapeutic company that fully powers the ADC development spectrum from a clinically relevant approach to target and functional antibody discovery to ADC creation, accelerating development and the delivery of effective therapies to patients. Founded in 2009, Igenica is led by a proven team of leaders that have demonstrated succ... ess in antibody drug discovery, clinical development and commercialization. Their leadership team has played a seminal role in six out of the 36 currently approved antibody therapeutic products. Based in Burlingame, Calif., they are well-funded by a premier team of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.

#SimilarOrganizations #People #Financial #Website #More

IGENICA

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2009-01-01

Address:
Burlingame, California, United States

Country:
United States

Website Url:
http://www.igenica.com

Total Employee:
11+

Status:
Active

Contact:
6506974900

Email Addresses:
[email protected]

Total Funding:
80.6 M USD

Technology used in webpage:
Amazon Google Maps Google Maps API Amazon Virginia Region Amazon S3 CDN Amazon Elastic Load Balancing Amazon ELB North Virginia


Similar Organizations

cti-biopharma-logo

CTI BioPharma

CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.

numab-logo

Numab

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.


Current Advisors List

not_available_image

Gwen Fyfe Board of Director @ Igenica
Board_member

david-goeddel_image

David Goeddel Chairman of the Board of Directors @ Igenica
Board_member

john-diekman_image

John Diekman Board of Directors @ Igenica
Board_member

carl-l-gordon_image

Carl L. Gordon Board of Directors @ Igenica
Board_member

robert-d-schreiber_image

Robert D. Schreiber Board of Directors @ Igenica
Board_member

richard-klausner_image

Richard Klausner Member of the Scientific Advisory Board @ Igenica
Advisor

richard-j-ulevitch_image

Richard J. Ulevitch Scientific Advisory Board @ Igenica
Advisor

mark-a-goldsmith_image

Mark A. Goldsmith Board of Directors @ Igenica
Board_member

Current Employees Featured

robert-d-schreiber_image

Robert D. Schreiber
Robert D. Schreiber Co-Founder @ Igenica
Co-Founder

hans-van-houte_image

Hans van Houte
Hans van Houte Chief Scientific Officer @ Igenica
Chief Scientific Officer

john-k-celebi_image

John K. Celebi
John K. Celebi Chief Business Officer @ Igenica
Chief Business Officer

Founder


not_available_image

Guoqing Chen

robert-d-schreiber_image

Robert D. Schreiber

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Igenica

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Igenica

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series C - Igenica

the-column-group_image

The Column Group

The Column Group investment in Series C - Igenica

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series C - Igenica

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series C - Igenica

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series C - Igenica

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Igenica

the-column-group_image

The Column Group

The Column Group investment in Series C - Igenica

the-column-group_image

The Column Group

The Column Group investment in Series B - Igenica

Official Site Inspections

http://www.igenica.com Semrush global rank: 2.89 M Semrush visits lastest month: 5.61 K

  • Host name: ec2-54-204-226-176.compute-1.amazonaws.com
  • IP address: 54.204.226.176
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Igenica"

Igenica Biotherapeutics - Assets - Crunchbase Company Profile

Organization. Igenica Biotherapeutics - Assets . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Igenica Biotherapeutics is the biotechnology โ€ฆSee details»

Igenica - Contacts, Employees, Board Members, Advisors & Alumni

Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.See details»

Igenica Biotherapeutics Inc - Company Profile and News

Company profile page for Igenica Biotherapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Igenica Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Explore Igenica Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 6 literature, Drug:IGN-786, IGN-523. ... The statistics for drugs in โ€ฆSee details»

Igenica - VentureRadar

Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative technology platforms to address the major โ€ฆSee details»

Igenica Biotherapeutics - Products, Competitors, Financials, โ€ฆ

Headquarters Location. 863 Mitten Rd Suite 102. Burlingame, California, 94010, United States. 650-697-4900See details»

Igenica Company Profile | Management and Employees List

Find contact information for Igenica. Learn about their Business Services market share, competitors, and Igenica's email format.See details»

Igenica - EquityNet

Igenica is a biopharmaceutical company dedicated to the discovery and development of breakthrough antibody-based therapeutics for the treatment of cancer. Although recombinant โ€ฆSee details»

Igenica - Company Profile - Tracxn

Igenica - Develops antibody-based cancer medicines. Raised a total funding of $102M over 9 rounds from 5 investors. Igenica has 2891 competitors.See details»

Igenica Biotherapeutics (immune oncology asset) - PitchBook

Igenica Biotherapeutics (immune oncology asset) General Information Description. A portfolio of immune oncology therapy assets. The assets provide immunotherapies targeting โ€ฆSee details»

Igenica | Scientist.com

Igenica is a biopharmaceutical company dedicated to serving the unmet needs of cancer patients through the discovery and development of breakthrough antibody-based therapeutics. ... Get โ€ฆSee details»

Igenica - Funding, Financials, Valuation & Investors - Crunchbase

Igenica is funded by 5 investors. National Institutes of Health and OrbiMed are the most recent investors. Igenica has a post-money valuation in the range of $100M to $500M as of Jun 9, โ€ฆSee details»

Igenica Inc. - BioCentury Company Profiles - BCIQ

Aug 9, 2022 Igenica Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Pierre Fabre to buy Igenica Biotherapeuticsโ€™ assets for treating โ€ฆ

May 25, 2017 French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica โ€ฆSee details»

Pierre Fabre Acquires Igenica Immuno-Oncology Assets

May 24, 2017 Based in Burlingame, CA, Igenica was established in 2009 and is focused on discovering and developing antibodies for immuno-oncology treatments as well as cancer โ€ฆSee details»

What does igenica mean? - Definitions.net

Definition of igenica in the Definitions.net dictionary. Meaning of igenica. What does igenica mean? Information and translations of igenica in the most comprehensive dictionary definitions โ€ฆSee details»

Igenica - Crunchbase

Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.See details»

What is Igenica? Company Culture, Mission, Values | Glassdoor

What is it really like to work at Igenica? Join the community to connect with real employees and see what other professionals are saying about their companies.See details»

Igenica Closes $33 Million in Series C Funding

Jun 12, 2012 About Igenica, Inc. Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative โ€ฆSee details»

linkstock.net © 2022. All rights reserved